P203: The clinical impact of genetic testing in infants with congenital heart disease
Abstract
Congenital Heart Disease (CHD) is the most common birth defect and has an identifiable genetic etiology in up to 25% of cases. As a result, many hospitals have incorporated genetic evaluation into CHD care, increasing genetic diagnoses and potentially improving immediate treatment planning, multidisciplinary care, and risk stratification. Given this diagnostic success, many physicians advocate for routine genetic screening in infants with CHD, regardless of lesion type or associated abnormalities.
Fields of Study & Subjects
Congenital Heart Disease Studies
Genomics and Rare Diseases
Congenital heart defects research
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 103697–103697
- Publication date
- 1 January 2026
- Language
- EN